+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Plavix"

From
From
From
Investigation Report on Clopidogrel in China, 2018-2022 - Product Thumbnail Image

Investigation Report on Clopidogrel in China, 2018-2022

  • Report
  • July 2018
  • 30 Pages
  • China
From
Plavix - Product Thumbnail Image

Plavix

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Ischemic Stroke Market and Forecast Analysis 2024 - Product Thumbnail Image

Ischemic Stroke Market and Forecast Analysis 2024

  • Drug Pipelines
  • January 2019
  • 163 Pages
  • Global
From
Plavix - API Insight, 2022 - Product Thumbnail Image

Plavix - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Plavix- Drug Insight, 2019 - Product Thumbnail Image

Plavix- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Plavix (clopidogrel) is a medication used to prevent blood clots in people with certain cardiovascular conditions. It is a thienopyridine class antiplatelet drug, which works by inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor and blocking the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. This reduces the ability of platelets to form clots, thus reducing the risk of stroke, heart attack, and other cardiovascular events. Plavix is used to treat acute coronary syndrome, peripheral artery disease, and other conditions. It is also used to reduce the risk of stroke and other cardiovascular events in people with a history of stroke or transient ischemic attack. The Plavix market is a subset of the larger cardiovascular drugs market, which includes medications used to treat and prevent cardiovascular diseases. This market includes drugs used to treat hypertension, dyslipidemia, and other cardiovascular conditions. It also includes drugs used to prevent and treat heart failure, arrhythmias, and other cardiovascular diseases. Companies in the Plavix market include Bristol-Myers Squibb, Sanofi, Pfizer, AstraZeneca, and Daiichi Sankyo. Show Less Read more